[Risk of differentiated thyroid cancer as the first and second primary tumor].

IF 0.9 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Orvosi hetilap Pub Date : 2025-02-16 DOI:10.1556/650.2025.33235
András Kiss, Balázs Szili, Bence Bakos, Bálint Tóbiás, Bernadett Balla, István Takács, Péter Lakatos, János Kósa
{"title":"[Risk of differentiated thyroid cancer as the first and second primary tumor].","authors":"András Kiss, Balázs Szili, Bence Bakos, Bálint Tóbiás, Bernadett Balla, István Takács, Péter Lakatos, János Kósa","doi":"10.1556/650.2025.33235","DOIUrl":null,"url":null,"abstract":"<p><p>Certain second primary malignancies have been reported to be more common after well differentiated thyroid cancer than it would be expected in the general population. Conversely, second primary thyroid cancers are more frequent following certain malignancies. In this review, the incidence of second primary malignancies after differentiated thyroid cancers and the risk of second primary thyroid cancer following the most common malignancies have been analyzed based on recent literature. The reported incidence of second primary malignancies might be influenced by study design, genetic predisposition, lifestyle, environmental factors, oncogenic treatment of the first malignancy and detection bias. Nevertheless, after thyroid cancer, a higher incidence of breast, prostate, colorectal, renal cancer, and certain hematological malignancies can be observed compared to the general population. Thyroid cancer occurs more frequently after breast, prostate, colorectal, lung, renal, and bladder cancer, certain hematological malignancies, and neuroblastoma. Long-term clinical follow-up is advised after thyroid cancer to ensure early detection of a possible second primary malignancy. Increased adherence to cancer screening programs is also highly recommended for survivors of the first primary thyroid cancer. Orv Hetil. 2025; 166(7): 253–262.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"166 7","pages":"253-262"},"PeriodicalIF":0.9000,"publicationDate":"2025-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2025.33235","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Certain second primary malignancies have been reported to be more common after well differentiated thyroid cancer than it would be expected in the general population. Conversely, second primary thyroid cancers are more frequent following certain malignancies. In this review, the incidence of second primary malignancies after differentiated thyroid cancers and the risk of second primary thyroid cancer following the most common malignancies have been analyzed based on recent literature. The reported incidence of second primary malignancies might be influenced by study design, genetic predisposition, lifestyle, environmental factors, oncogenic treatment of the first malignancy and detection bias. Nevertheless, after thyroid cancer, a higher incidence of breast, prostate, colorectal, renal cancer, and certain hematological malignancies can be observed compared to the general population. Thyroid cancer occurs more frequently after breast, prostate, colorectal, lung, renal, and bladder cancer, certain hematological malignancies, and neuroblastoma. Long-term clinical follow-up is advised after thyroid cancer to ensure early detection of a possible second primary malignancy. Increased adherence to cancer screening programs is also highly recommended for survivors of the first primary thyroid cancer. Orv Hetil. 2025; 166(7): 253–262.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
【分化型甲状腺癌作为第一和第二原发肿瘤的风险】。
据报道,某些第二原发性恶性肿瘤在分化良好的甲状腺癌后比在一般人群中更常见。相反,第二原发性甲状腺癌在某些恶性肿瘤之后更常见。本文结合近期文献,对分化型甲状腺癌后第二原发恶性肿瘤的发生率和最常见恶性肿瘤后第二原发甲状腺癌的发生风险进行分析。报告的第二原发恶性肿瘤发生率可能受研究设计、遗传易感性、生活方式、环境因素、第一恶性肿瘤的致癌治疗和检测偏差的影响。然而,在甲状腺癌之后,乳腺癌、前列腺癌、结直肠癌、肾癌和某些血液系统恶性肿瘤的发病率高于一般人群。甲状腺癌在乳腺癌、前列腺癌、结直肠癌、肺癌、肾癌和膀胱癌、某些血液系统恶性肿瘤和神经母细胞瘤之后更常发生。建议长期临床随访后甲状腺癌,以确保早期发现可能的第二原发恶性肿瘤。对于第一原发性甲状腺癌的幸存者,也强烈建议增加对癌症筛查项目的依从性。Orv Hetil. 2025;166(7): 253 - 262。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
期刊最新文献
[NeoTracker - a self-developed digital event log in delivery room stabilization of newborn infants]. [Necrotizing pneumonia in children - case report of a severe disease]. [Novel T-cell clonality assessment using T-cell receptor beta constant region 1 and 2 antibodies in T-cell lymphoproliferative disorders]. [Professor János Hankiss is 100 years old]. [The role of psychological factors in the frequency and experience of menstrual symptoms: negative affect and somatosensory amplification].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1